These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 28902040

  • 1. Long-term rifaximin therapy as a primary prevention of hepatorenal syndrome.
    Ibrahim ES, Alsebaey A, Zaghla H, Moawad Abdelmageed S, Gameel K, Abdelsameea E.
    Eur J Gastroenterol Hepatol; 2017 Nov; 29(11):1247-1250. PubMed ID: 28902040
    [Abstract] [Full Text] [Related]

  • 2. Rifaximin Decreases the Incidence and Severity of Acute Kidney Injury and Hepatorenal Syndrome in Cirrhosis.
    Dong T, Aronsohn A, Gautham Reddy K, Te HS.
    Dig Dis Sci; 2016 Dec; 61(12):3621-3626. PubMed ID: 27655104
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The role of rifaximin in the primary prophylaxis of spontaneous bacterial peritonitis in patients with liver cirrhosis.
    Hanouneh MA, Hanouneh IA, Hashash JG, Law R, Esfeh JM, Lopez R, Hazratjee N, Smith T, Zein NN.
    J Clin Gastroenterol; 2012 Sep; 46(8):709-15. PubMed ID: 22878533
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Long-term administration of rifaximin improves the prognosis of patients with decompensated alcoholic cirrhosis.
    Vlachogiannakos J, Viazis N, Vasianopoulou P, Vafiadis I, Karamanolis DG, Ladas SD.
    J Gastroenterol Hepatol; 2013 Mar; 28(3):450-5. PubMed ID: 23216382
    [Abstract] [Full Text] [Related]

  • 7. Rifaximin and midodrine improve clinical outcome in refractory ascites including renal function, weight loss, and short-term survival.
    Hanafy AS, Hassaneen AM.
    Eur J Gastroenterol Hepatol; 2016 Dec; 28(12):1455-1461. PubMed ID: 27622998
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The efficacy and the immunomodulatory effect of rifaximin in prophylaxis of spontaneous bacterial peritonitis in cirrhotic Egyptian patients.
    Mostafa T, Badra G, Abdallah M.
    Turk J Gastroenterol; 2015 Mar; 26(2):163-9. PubMed ID: 25835116
    [Abstract] [Full Text] [Related]

  • 13. Is there any potential or additive effect of anemia on hepatorenal syndrome?
    Güngör G, Akyıldız M, Keskin M, Solak Y, Gaipov A, Bıyık M, Çifçi S, Ataseven H, Polat H, Demir A.
    Turk J Gastroenterol; 2016 May; 27(3):273-8. PubMed ID: 27210785
    [Abstract] [Full Text] [Related]

  • 14. Serum sodium identifies patients with cirrhosis at high risk of hepatorenal syndrome.
    Janičko M, Veselíny E, Abraldes JG, Jarčuška P.
    Z Gastroenterol; 2013 Jul; 51(7):628-34. PubMed ID: 23696114
    [Abstract] [Full Text] [Related]

  • 15. Rifaximin treatment is associated with reduced risk of cirrhotic complications and prolonged overall survival in patients experiencing hepatic encephalopathy.
    Kang SH, Lee YB, Lee JH, Nam JY, Chang Y, Cho H, Yoo JJ, Cho YY, Cho EJ, Yu SJ, Kim MY, Kim YJ, Baik SK, Yoon JH.
    Aliment Pharmacol Ther; 2017 Nov; 46(9):845-855. PubMed ID: 28836723
    [Abstract] [Full Text] [Related]

  • 16. Effect of different therapeutic modalities on systemic, renal, and hepatic hemodynamics and short-term outcomes in cirrhotic patients with spontaneous bacterial peritonitis.
    Salman TA, Edrees AM, El-Said HH, El-Abd OL, El-Azab GI.
    Eur J Gastroenterol Hepatol; 2016 Jul; 28(7):777-85. PubMed ID: 27097354
    [Abstract] [Full Text] [Related]

  • 17. Serum cystatin C in advanced liver cirrhosis and different stages of the hepatorenal syndrome.
    Barakat M, Khalil M.
    Arab J Gastroenterol; 2011 Sep; 12(3):131-5. PubMed ID: 22055590
    [Abstract] [Full Text] [Related]

  • 18. Effect of low dose albumin administration in spontaneous bacterial peritonitis on renal function and survival.
    Elloumi H, Sabbah M, Bibani N, Trad D, Elleuch N, Gargouri D, Ouakaa A, Kharrat J.
    Arab J Gastroenterol; 2019 Dec; 20(4):205-208. PubMed ID: 31759874
    [Abstract] [Full Text] [Related]

  • 19. Predictors of hepatorenal syndrome in alcoholic liver cirrhosis.
    Janicko M, Veseliny E, Senajova G, Jarcuska P.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Dec; 159(4):661-5. PubMed ID: 25820623
    [Abstract] [Full Text] [Related]

  • 20. Spontaneous bacterial peritonitis by Pasteurella multocida under treatment with rifaximin.
    Lutz P, Parcina M, Bekeredjian-Ding I, Hoerauf A, Strassburg CP, Spengler U.
    Infection; 2014 Feb; 42(1):175-7. PubMed ID: 23526308
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.